Calcium-activated chloride channel is involved in the onset of diarrhea triggered by EGFR tyrosine kinase inhibitor treatment in rats
出版年份 2021 全文链接
标题
Calcium-activated chloride channel is involved in the onset of diarrhea triggered by EGFR tyrosine kinase inhibitor treatment in rats
作者
关键词
CaCC, EGFR-TKI, Diarrhea, Therapy, Hangeshashinto
出版物
BIOMEDICINE & PHARMACOTHERAPY
Volume 141, Issue -, Pages 111860
出版商
Elsevier BV
发表日期
2021-07-09
DOI
10.1016/j.biopha.2021.111860
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Plasma membrane–localized TMEM16 proteins are indispensable for expression of CFTR
- (2019) Roberta Benedetto et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- The characterization, management, and future considerations for ErbB-family TKI-associated diarrhea
- (2019) Hope S. Rugo et al. BREAST CANCER RESEARCH AND TREATMENT
- Efficacy and safety of hangeshashinto for treatment of GERD refractory to proton pump inhibitors
- (2019) Toshihisa Takeuchi et al. JOURNAL OF GASTROENTEROLOGY
- Anoctamin 1/TMEM16A controls intestinal Cl− secretion induced by carbachol and cholera toxin
- (2019) Byeongjun Lee et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Efficacy of herbal medicine TJ-14 for acute radiation-induced enteritis: a multi-institutional prospective Phase II trial
- (2019) Taro Murai et al. JOURNAL OF RADIATION RESEARCH
- Control of Ion Transport by Tmem16a Expressed in Murine Intestine
- (2019) Karl Kunzelmann et al. Frontiers in Physiology
- Resveratrol dimer trans-ε -viniferin prevents rotaviral diarrhea in mice by inhibition of the intestinal calcium-activated chloride channel
- (2018) Bo Yu et al. PHARMACOLOGICAL RESEARCH
- Therapeutic Strategies in EGFR Mutant Non-Small Cell Lung Cancer
- (2018) Herbert H. Loong et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Recent advances in TMEM16A: Structure, function, and disease
- (2018) Qiushuang Ji et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Role of ErbB/HER family of receptor tyrosine kinases in cholangiocyte biology
- (2017) Anna Pellat et al. HEPATOLOGY
- A review on adverse event profiles of epidermal growth factor receptor-tyrosine kinase inhibitors in nonsmall cell lung cancer patients
- (2017) B Biswas et al. INDIAN JOURNAL OF CANCER
- The Role of ErbB Receptors in Infection
- (2017) Jemima Ho et al. TRENDS IN MICROBIOLOGY
- Preventive effect of kampo medicine (hangeshashin-to, TJ-14) plus minocycline against afatinib-induced diarrhea and skin rash in patients with non-small cell lung cancer
- (2017) Masao Ichiki et al. OncoTargets and Therapy
- A review on adverse event profiles of epidermal growth factor receptor-tyrosine kinase inhibitors in nonsmall cell lung cancer patients
- (2017) B Biswas et al. INDIAN JOURNAL OF CANCER
- Epithelial Chloride Transport by CFTR Requires TMEM16A
- (2017) Roberta Benedetto et al. Scientific Reports
- Osimertinib for the Treatment of Metastatic EGFR T790M Mutation–Positive Non–Small Cell Lung Cancer
- (2016) Sean Khozin et al. CLINICAL CANCER RESEARCH
- The safety of afatinib for the treatment of non-small cell lung cancer
- (2016) Feliciano Barron et al. Expert Opinion On Drug Safety
- Shikonin Inhibits Intestinal Calcium-Activated Chloride Channels and Prevents Rotaviral Diarrhea
- (2016) Yu Jiang et al. Frontiers in Pharmacology
- ErbB small molecule tyrosine kinase inhibitor (TKI) induced diarrhoea: Chloride secretion as a mechanistic hypothesis
- (2015) Ysabella Z.A. Van Sebille et al. CANCER TREATMENT REVIEWS
- Pooled safety analysis of EGFR-TKI treatment for EGFR mutation-positive non-small cell lung cancer
- (2015) Masayuki Takeda et al. LUNG CANCER
- Secretory diarrhoea: mechanisms and emerging therapies
- (2015) Jay R. Thiagarajah et al. Nature Reviews Gastroenterology & Hepatology
- Management of diarrhea induced by epidermal growth factor receptor tyrosine kinase inhibitors
- (2014) V. Hirsh et al. Current Oncology
- Multitargeted Effects of Hangeshashinto for Treatment of Chemotherapy-Induced Oral Mucositis on Inducible Prostaglandin E2 Production in Human Oral Keratinocytes
- (2014) Toru Kono et al. INTEGRATIVE CANCER THERAPIES
- Guidance on the management of diarrhoea during cancer chemotherapy
- (2014) Jervoise Andreyev et al. LANCET ONCOLOGY
- Safety and efficacy of neratinib in combination with weekly paclitaxel and trastuzumab in women with metastatic HER2-positive breast cancer: an NSABP Foundation Research Program phase I study
- (2013) Rachel C. Jankowitz et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Targeted therapy-induced diarrhea: A review of the literature
- (2013) M.A. Pessi et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Chloride channel-targeted therapy for secretory diarrheas
- (2013) Jay R Thiagarajah et al. CURRENT OPINION IN PHARMACOLOGY
- Diarrhea associated with afatinib: an oral ErbB family blocker
- (2013) James Chih-Hsin Yang et al. Expert Review of Anticancer Therapy
- Chloride channel inhibition by a red wine extract and a synthetic small molecule prevents rotaviral secretory diarrhoea in neonatal mice
- (2013) Eun-A Ko et al. GUT
- ErbB receptors and their growth factor ligands in pediatric intestinal inflammation
- (2013) Mark R. Frey et al. PEDIATRIC RESEARCH
- Development of a rat model of oral small molecule receptor tyrosine kinase inhibitor-induced diarrhea
- (2012) Joanne M. Bowen et al. CANCER BIOLOGY & THERAPY
- Managing treatment-related adverse events associated with egfr tyrosine kinase inhibitors in advanced non-small-cell lung cancer
- (2011) V. Hirsh Current Oncology
- Rotavirus toxin NSP4 induces diarrhea by activation of TMEM16A and inhibition of Na+ absorption
- (2011) Jiraporn Ousingsawat et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- The Intestinotrophic Peptide, GLP-2, Counteracts the Gastrointestinal Atrophy in Mice Induced by the Epidermal Growth Factor Receptor Inhibitor, Erlotinib, and Cisplatin
- (2010) Andreas Rosén Rasmussen et al. DIGESTIVE DISEASES AND SCIENCES
- ErbB Signaling Is Required for the Proliferative Actions of GLP-2 in the Murine Gut
- (2009) Bernardo Yusta et al. GASTROENTEROLOGY
- Clinical Efficacy and Toxicity of Anti-EGFR Therapy in Common Cancers
- (2009) Amir Harandi et al. Journal of Oncology
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started